Skip to content

FITBONE® TAA1140-F-205Recalls & reported problems

WITTENSTEIN intens GmbH · Intramedullary lengthening nail · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04260170143938), received between Feb 12, 2021 and Feb 12, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Therapeutic or Diagnostic Output Failure” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Therapeutic or Diagnostic Output Failure1

Patient problems

  • Insufficient Information1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 12, 2021Therapeutic or Diagnostic Output Failure

    INFORMATION PROVIDED STATES THAT THE PATIENT HAD A FITBONE NAIL IMPLANTED IN THE FEMUR ON (B)(6) 2020. IT WAS NOTICED DURING A POST-OP VISIT ON (B)(6) 2021 THAT THERE WAS NO LENGTHENING OF THE NAIL. THE DISTRIBUTOR REPRESENTATIVE TESTED THE NAIL FOR DISTRACTION ON (B)(6) 2021 USING A 2ND CONTROL UNIT. THE NAIL FAILED TO LENGTHEN WITH THE NEW CONTROL UNIT. A REVISION SURGERY WILL BE SCHEDULED TO FURTHER PATIENT'S TREATMENT.

    Patient problems: Insufficient Information

    MAUDE report 11325533 ↗

Other Rod, Fixation, Intramedullary And Accessories devices

All Rod, Fixation, Intramedullary And Accessories devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page